La chaîne d'options affiche les données clés des options sur actions de Co-Diagnostics à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Co-Diagnostics..

Co-Diagnostics (NASDAQ:CODX) Stock, Chaîne d'Options

CO-DIAGNOSTICS INC

Co-Diagnostics

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Co-Diagnostics Inc

Press Releases

Co-Diagnostics, Inc. Announces Second Quarter 2025 Earnings Release Date and Webcast

Earnings

Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results

Co-Diagnostics, Inc. to Host Booth at 17th Next Generation Dx Summit in Washington, D.C.

Co-Diagnostics, Inc. Honored at Utah Business 2025 Innovation Awards Summit

Co-Diagnostics, Inc. Performs Analysis of Chikungunya Co-Primers® to Confirm Reactivity Against Known Virus Strains

Co-Diagnostics, Inc. Signs Strategic MOU with Partner in Kingdom of Saudi Arabia to Introduce Co-Dx™ PCR Platform to Middle East

Offerings

Co-Diagnostics, Inc. Announces Pricing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Small Cap

Co-Diagnostics, Inc. Announces Closing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Co-Diagnostics, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30

Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit

CODX

Adagio Medical Holdings, Inc - Common Stock

Adagio Medical Holdings

Check-Cap

Envoy Medical, Inc. - Class A Common Stock

Envoy Medical

electroCore

Ekso Bionics Holdings, Inc. - Common Stock

Ekso Bionics Holdings

Femasys

HeartSciences

SeaStar Medical Holding Corporation - Common Stock

SeaStar Medical Holding

Inspira Technologies Oxy B.H.N. Ltd. - Ordinary Shares

Inspira Technologies Oxy

Intelligent Bio Solutions Inc. - Common Stock

Intelligent Bio Solutions

Iridex

Lifeward

Modular Medical

Neuraxis

enVVeno Medical Corporation - Common Stock

enVVeno Medical

Nexalin Technology

PAVmed

Profusa

Predictive Oncology

Precision Optics Corporation, Inc. - Common stock

Precision Optics Corp

Vicarious Surgical Inc. Class A Common Stock

Vicarious Surgical

SINTX Technologies

Tenon Medical

Trinity Biotech plc - American Depositary Shares

Comments

Co-Diagnostics

Co-Diagnostics (CODX) Options

Co-Diagnostics (NASDAQ:CODX) Stock, Chaîne d'Options

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL